“…Established therapies, including glucocorticoid and immunosuppressive agents can take a long time to heal the wounds and, additionally, not all patients respond well to these treatments [1]. In recent years, endothelial progenitor cells (EPCs) [2], bone-marrow-derived mononuclear cells (BM-MNCs) [3], fibrocytes [4] and karotinocytes [5] have been shown to be helpful in the healing process of leg ulcers. In a rat diabetic wound healing model, systemic and local treatment with bone-marrow-derived mesenchymal stem cells (BM-MSCs) also demonstrated efficacy [6].…”